가축 건강 관리 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 질병 유형별, 동물 유형별, 유통 채널별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Cattle Healthcare Market size was valued at USD 8.9 billion in 2024 and is poised to grow from USD 9.35 billion in 2025 to USD 13.93 billion by 2033, growing at a CAGR of 5.1% during the forecast period (2026-2033).

The global cattle healthcare market is experiencing rapid growth, driven by the surging demand for animal protein fueled by population growth and increasing incomes. As consumers prioritize higher quality meat and milk, livestock producers are adopting advanced healthcare solutions to maintain herd health and enhance productivity. The rise of zoonotic diseases necessitates robust disease management via vaccines, medications, and routine health assessments, which ensure both animal welfare and food safety. Technological advancements, such as wearable sensors and telemedicine, are revolutionizing cattle healthcare through improved monitoring and disease detection, enabling customized treatment and effective herd management. However, challenges remain due to high costs of veterinary services and products, a shortage of qualified veterinarians, and regulatory hurdles, particularly impacting farmers in impoverished regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cattle Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cattle Healthcare Market Segments Analysis

Global Cattle Healthcare Market is segmented by Product Type, Disease Type, Animal Type, Distribution Channel, End User and region. Based on Product Type, the market is segmented into Pharmaceuticals, Feed Additives, Diagnostics and Medical Devices & Equipment. Based on Disease Type, the market is segmented into Infectious Diseases, Parasitic Diseases, Metabolic Disorders, Reproductive Disorders, Mastitis, Respiratory Diseases and Others. Based on Animal Type, the market is segmented into Dairy Cattle, Beef Cattle and Calves. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Channels, Direct Sales and Others. Based on End User, the market is segmented into Dairy Farms, Cattle Farms, Veterinary Institutions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cattle Healthcare Market

The global Cattle Healthcare market is being significantly driven by advancements in technology such as precision livestock farming, wearable biosensors, and artificial intelligence-powered health monitoring systems. These innovations facilitate early disease detection and continuous monitoring of vital signs, alongside optimizing feeding and breeding practices, thereby improving herd health and productivity. The integration of telemedicine with digital record-keeping enhances veterinary accessibility and aids in informed decision-making. Furthermore, breakthroughs in vaccine development, genetic screening, and drug delivery methods ensure more effective treatments for cattle, reducing morbidity and mortality rates, and fostering a greater demand for advanced veterinary solutions worldwide.

Restraints in the Global Cattle Healthcare Market

The Global Cattle Healthcare market faces significant challenges due to inadequate infrastructure. The lack of veterinary clinics, proper cold chain storage for vaccines, and reliable transportation systems hinders the delivery of essential veterinary care, particularly in remote and underserved regions. Many rural communities struggle with accessing veterinary supplies, diagnostics, and professional services, complicating timely support during animal health crises. Furthermore, poor internet connectivity restricts the implementation of advanced monitoring systems and telemedicine. These logistical and infrastructural deficiencies contribute to the limited adoption of innovative cattle healthcare solutions, acting as a primary obstacle to market growth and development.

Market Trends of the Global Cattle Healthcare Market

The Global Cattle Healthcare market is witnessing a significant shift towards preventive health measures, driven by an increasing awareness of the economic implications of livestock diseases. Farmers are prioritizing vaccination and nutrition-based immunity enhancers to bolster herd health, moving away from reactive treatments. This trend reflects a holistic approach to cattle management, emphasizing sustainability and cost-effectiveness. As the prevalence of diseases, such as Bovine Respiratory Disease, continues to impact productivity, there is a growing reliance on preventive solutions. Consequently, demand for advanced vaccine portfolios and health management strategies is on the rise, reshaping the landscape of cattle healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Cattle Healthcare Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Pharmaceuticals
  • Vaccines
  • Antibiotics
  • Anti-inflammatory Drugs
  • Parasiticides
  • Others
• Feed Additives
  • Vitamins & Minerals
  • Amino Acids
  • Probiotics
  • Enzymes
  • Others
• Diagnostics
  • Immunodiagnostics
  • Molecular Diagnostics
  • Clinical Chemistry
  • Others
• Medical Devices & Equipment
  • Surgical Instruments
  • Monitoring Devices
  • Imaging Equipment
  • Others

Global Cattle Healthcare Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Infectious Diseases
• Parasitic Diseases
• Metabolic Disorders
• Reproductive Disorders
• Mastitis
• Respiratory Diseases
• Others

Global Cattle Healthcare Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dairy Cattle
• Beef Cattle
• Calves

Global Cattle Healthcare Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Channels
• Direct Sales
• Others

Global Cattle Healthcare Market Size by End User & CAGR (2026-2033)

• Market Overview
• Dairy Farms
• Cattle Farms
• Veterinary Institutions
• Others

Global Cattle Healthcare Market Size & CAGR (2026-2033)

• North America (Product Type, Disease Type, Animal Type, Distribution Channel, End User)
  • US
  • Canada
• Europe (Product Type, Disease Type, Animal Type, Distribution Channel, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Disease Type, Animal Type, Distribution Channel, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Disease Type, Animal Type, Distribution Channel, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Disease Type, Animal Type, Distribution Channel, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hester Biosciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda Holdings PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoritsu Seiyaku Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeQuent Scientific Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations